Day: October 19, 2021

Avadel Presents New Data Supporting Clinical Benefit with Once-at-Bedtime FT218 and Preference for Once-Nightly Dosing in Patients with Narcolepsy at CHEST 2021

- Post-hoc responder analyses demonstrated a significantly greater proportion of patients receiving FT218 experienced reductions in weekly cataplexy attacks and...

X4 Pharmaceuticals Expands Commercial Leadership Expertise with Appointment of Françoise de Craecker to Board of Directors and Karolyn Park as Vice President, U.S. Commercial

Each brings significant experience in strategic marketing of rare disease therapeutics and commercial operationsBOSTON, Oct. 19, 2021 (GLOBE NEWSWIRE) --...

error: Content is protected !!